These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 24286577)

  • 41. New drugs: big changes in conservative heart failure therapy?
    Berliner D; Bauersachs J
    Eur J Cardiothorac Surg; 2019 Jun; 55(Suppl 1):i3-i10. PubMed ID: 31106335
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Therapeutic options of Angiotensin Receptor Neprilysin inhibitors (ARNis) in chronic heart failure with reduced ejection fraction: Beyond RAAS and sympathetic nervous system inhibition.
    Volterrani M; Iellamo F; Senni M; Piepoli MF
    Int J Cardiol; 2017 Jan; 226():132-135. PubMed ID: 27184730
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Renal sequelae of sympathetic hyperactivity].
    Watschinger B; Habicht A
    Wien Med Wochenschr; 2004; 154 Spec No 1(1):7-9. PubMed ID: 15346546
    [No Abstract]   [Full Text] [Related]  

  • 44. Variation in use and dosing escalation of renin angiotensin system, mineralocorticoid receptor antagonist, angiotensin receptor neprilysin inhibitor and beta-blocker therapies in heart failure and reduced ejection fraction: Association of comorbidities.
    Albert NM; Tyson RJ; Hill CL; DeVore AD; Spertus JA; Duffy C; Butler J; Patterson JH; Hernandez AF; Williams FB; Thomas L; Fonarow GC
    Am Heart J; 2021 May; 235():82-96. PubMed ID: 33497697
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Management of ACCF/AHA Stage C heart failure.
    Adigopula S; Vivo RP; DePasquale EC; Nsair A; Deng MC
    Cardiol Clin; 2014 Feb; 32(1):73-93, viii. PubMed ID: 24286580
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Hormonal theory of heart failure with altered systolic function].
    Arnoult F; Phan G; Detaint D; Caligiuri G; Aumont MC; Mercadier JJ; Jondeau G
    Rev Med Interne; 2010 Oct; 31(10):721-5. PubMed ID: 20864226
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Congestive heart failure and renal complications.
    Del Rio-Santiago VJ; Rodriguez-Ospina L; Córdova HR; Vicenty SI
    Bol Asoc Med P R; 2008; 100(4):29-37. PubMed ID: 19400527
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Neurohormonal factors in heart failure. I].
    Cosín Aguilar J; Cruz Fernández JM; de Teresa Galván E; Ferreira Montero IJ; López-Sendón J; Soler Soler J; Tamargo Menéndez J
    Rev Esp Cardiol; 1996 Apr; 49(4):239-52. PubMed ID: 8650399
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The renin-angiotensin and adrenergic nervous system in cardiac hypertrophy in fructose-fed rats.
    Kamide K; Rakugi H; Higaki J; Okamura A; Nagai M; Moriguchi K; Ohishi M; Satoh N; Tuck ML; Ogihara T
    Am J Hypertens; 2002 Jan; 15(1 Pt 1):66-71. PubMed ID: 11824863
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The sympathetic nervous system and ischaemic heart disease.
    Remme WJ
    Eur Heart J; 1998 Jun; 19 Suppl F():F62-71. PubMed ID: 9651738
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Renin angiotensin aldosterone and adrenergic modulation in chronic heart failure: contemporary concepts.
    Mehra MR; Uber PA; Potluri S
    Am J Med Sci; 2002 Nov; 324(5):267-75. PubMed ID: 12449448
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Acute effects of angiotensin-converting enzyme inhibition versus angiotensin II receptor blockade on cardiac sympathetic activity in patients with heart failure.
    Azevedo ER; Mak S; Floras JS; Parker JD
    Am J Physiol Regul Integr Comp Physiol; 2017 Oct; 313(4):R410-R417. PubMed ID: 28679681
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Does aldosterone upregulate the brain renin-angiotensin system in rats with heart failure?
    Yu Y; Wei SG; Zhang ZH; Gomez-Sanchez E; Weiss RM; Felder RB
    Hypertension; 2008 Mar; 51(3):727-33. PubMed ID: 18227408
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Nonselective versus selective beta-adrenergic receptor blockade in congestive heart failure: differential effects on sympathetic activity.
    Azevedo ER; Kubo T; Mak S; Al-Hesayen A; Schofield A; Allan R; Kelly S; Newton GE; Floras JS; Parker JD
    Circulation; 2001 Oct; 104(18):2194-9. PubMed ID: 11684630
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The renin-angiotensin-aldosterone system and heart failure.
    Sayer G; Bhat G
    Cardiol Clin; 2014 Feb; 32(1):21-32, vii. PubMed ID: 24286576
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Heart failure update: treatment of heart failure with a normal left ventricular ejection fraction in the elderly.
    Aronow WS
    Geriatrics; 2006 Aug; 61(8):16-20. PubMed ID: 16901193
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Treatment of heart failure with preserved systolic function.
    de Groote P; Herpin D; Diévart F; Hanon O; Trochu JN; Artigou JY; Galinier M; Habib G; Juillière Y; Neuder Y; Roudaut R; Komajda M
    Arch Cardiovasc Dis; 2008 May; 101(5):361-72. PubMed ID: 18656095
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Heart failure.
    McKelvie R
    Clin Evid; 2004 Dec; (12):115-43. PubMed ID: 15865633
    [No Abstract]   [Full Text] [Related]  

  • 59. Pharmacotherapy for systolic dysfunction: a review of randomized clinical trials.
    Gheorghiade M; Benatar D; Konstam MA; Stoukides CA; Bonow RO
    Am J Cardiol; 1997 Oct; 80(8B):14H-27H. PubMed ID: 9372994
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Brain renin-angiotensin system and sympathetic hyperactivity in rats after myocardial infarction.
    Zhang W; Huang BS; Leenen FH
    Am J Physiol; 1999 May; 276(5):H1608-15. PubMed ID: 10330245
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.